de Jong Bouke C, Hill Philip C, Brookes Roger H, Gagneux Sebastien, Jeffries David J, Otu Jacob K, Donkor Simon A, Fox Annette, McAdam Keith P W J, Small Peter M, Adegbola Richard A
Medical Research Council Laboratories, The Gambia.
J Infect Dis. 2006 May 1;193(9):1279-86. doi: 10.1086/502977. Epub 2006 Mar 31.
Mycobacterium africanum, a member of the M. tuberculosis complex that is infrequently found outside of western Africa, is the cause of up to half of the tuberculosis cases there.
We genotyped mycobacterial isolates obtained from a study of patients with tuberculosis and their household contacts and compared T cell responses and tuberculin skin test results by infecting genotype.
The T cell response to early secreted antigenic target, 6 kDa (ESAT-6), was attenuated in patients with tuberculosis (odds ratio [OR], 0.41 [95% confidence interval {CI}, 0.19-0.89]; P = .024) and household contacts (OR, 0.56 [95% CI, 0.38-0.83]; P = .004) infected with M. africanum, compared with the response in those infected with M. tuberculosis. In these same groups, responses to culture filtrate protein, 10 kDa (CFP-10), were nonsignificantly attenuated (P = .22 and P = .16, respectively), as were tuberculin skin test results (P = .30 and P = .46, respectively). Sequencing of region of difference 1 of M. africanum revealed that Rv3879c is a pseudogene in M. africanum; however, this finding does not provide an obvious mechanism for the attenuated ESAT-6 response.
This is the first evidence, to our knowledge, that strain differences affect interferon- gamma -based T cell responses. Our findings highlight the need to test new diagnostic candidates against different strains of mycobacteria. Integrating additional immunologic and genomic comparisons of M. tuberculosis and M. africanum into further studies may provide fundamental insights into the interactions between humans and mycobacteria.
非洲分枝杆菌是结核分枝杆菌复合群的成员之一,在西非以外地区很少见,是该地区多达一半结核病病例的病因。
我们对从结核病患者及其家庭接触者研究中获得的分枝杆菌分离株进行基因分型,并通过感染基因型比较T细胞反应和结核菌素皮肤试验结果。
与感染结核分枝杆菌的患者相比,感染非洲分枝杆菌的结核病患者(优势比[OR],0.41[95%置信区间{CI},0.19 - 0.89];P = 0.024)和家庭接触者(OR,0.56[95%CI,0.38 - 0.83];P = 0.004)对早期分泌性抗原靶标6 kDa(ESAT - 6)的T细胞反应减弱。在这些相同的组中,对10 kDa培养滤液蛋白(CFP - 10)的反应无显著减弱(分别为P = 0.22和P = 0.16),结核菌素皮肤试验结果也是如此(分别为P = 0.30和P = 0.46)。非洲分枝杆菌差异区域1的测序显示,Rv3879c在非洲分枝杆菌中是一个假基因;然而,这一发现并未为减弱的ESAT - 6反应提供明显的机制。
据我们所知,这是菌株差异影响基于干扰素 - γ的T细胞反应的首个证据。我们的研究结果强调了针对不同分枝杆菌菌株测试新诊断候选物的必要性。将结核分枝杆菌和非洲分枝杆菌的更多免疫和基因组比较纳入进一步研究可能会为人类与分枝杆菌之间的相互作用提供基本见解。